Search
Schinus terebinthifolia pollen
go.drugbank.com/drugs/DB21762ApprovedSchinus terebinthifolia pollen is mainly used in allergenic testing.
Butyric Acid
go.drugbank.com/drugs/DB03568InvestigationalA four carbon acid, CH3CH2CH2COOH, with an unpleasant odor that occurs in butter and animal fat as the glycerol ester.
Synonyms: N-butyric acid, N-butanoic acidCanis lupus familiaris skin
go.drugbank.com/drugs/DB10409ApprovedCanis lupus familiaris skin allergenic extract is used in allergenic testing.
Cedar oil
go.drugbank.com/drugs/DB10917ApprovedCedar oil (Juniperus virginiana) allergenic extract is used in allergenic testing.
Chlormerodrin
go.drugbank.com/drugs/DB00534ApprovedWithdrawnChlormerodrin is a mercurial compound with toxic side effects that was previously used as a diuretic. The radiolabeled form has been used as a diagnostic and research tool. It is no longer used and has been replaced with new classes of d...
Anti-SARS-CoV-2 REGN-COV2
go.drugbank.com/drugs/DB15691Investigationalincluding contacts of an infected individual. … [L14306] Clinical trials for this drug started on June 11, 2020.
Xylazine
go.drugbank.com/drugs/DB11477InvestigationalVet approvedXylazine is a clonidine analog used as a non-opioid tranquilizer in veterinary medicine and as an emetic, especially in cats. … [L42675] Xylazine is sometimes used as an adulterant and combined with opioids and recreational drugs; however, it has no antidote, and the use of [naloxone] has no effect on xylazine.[L42675,L42680]
SPP1148
go.drugbank.com/drugs/DB05203ExperimentalSPP1148, the most promising compound from a new series of renin inhibitors for the treatment of hypertension and related end-organ disease.
Pascolizumab
go.drugbank.com/drugs/DB06560InvestigationalPascolizumab (SB 240683) is a humanized anti-interleukin-4 antibody with therapeutic potential in asthma.
IR208
go.drugbank.com/drugs/DB05106InvestigationalIt contains three peptides (BV5S2, BV6S5 and BV13S1) expressed by T-Cells in over 90% of MS patients. IR208 is currently undergoing Phase II studies in a 200-patient trial.